Cytosorbents Cor (CTSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 9,421 | 9,450 | 9,391 | 8,111 | 8,496 |
| Cost of Goods | 3,402 | 3,994 | 3,633 | 4,494 | 3,551 |
| Gross Profit | 6,019 | 5,455 | 5,757 | 3,617 | 4,945 |
| Operating Expenses | 12,980 | 14,341 | 12,747 | 13,129 | 13,853 |
| Operating Income | -6,559 | -7,892 | -6,356 | -9,017 | -8,357 |
| Other Income | 406 | 566 | 4,498 | -3,184 | -2,522 |
| Pre-tax Income | -6,153 | -7,326 | -1,859 | -12,201 | -10,879 |
| Net Income Continuous | -6,153 | -7,326 | -766 | -12,201 | -10,879 |
| Net Income | $-6,153 | $-7,326 | $-766 | $-12,201 | $-10,879 |
| EPS Basic Total Ops | -0.14 | -0.17 | -0.01 | -0.28 | -0.25 |
| EPS Basic Continuous Ops | -0.14 | -0.17 | -0.02 | -0.28 | -0.25 |
| EPS Diluted Total Ops | -0.14 | -0.17 | -0.01 | -0.28 | -0.25 |
| EPS Diluted Continuous Ops | -0.14 | -0.17 | -0.02 | -0.28 | -0.25 |
| EBITDA(a) | $-6,102 | $-7,578 | $-6,078 | $-8,740 | $-8,064 |